Medtronic's Reveal Cardiac Monitor: Key to AF Detection - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 2:15PM CST
The incremental cost-effectiveness ratio (ICER) associated with the utilization of Medtronic's (MDT) Reveal XT ICM came well within the cost-effectiveness range supported by the United Kingdom's National Institute of Clinical Excellence.
CSII: 35.69 (+0.17), MDT: 75.26 (+0.33), PAHC: 30.85 (+0.36), ABAX: 60.93 (+0.65)
Phibro Animal Health: Market Expansion And New Contracts To Drive Earnings Growth
Ross Capital - at Seeking Alpha - Fri Feb 13, 10:35AM CST
PAHC: 30.85 (+0.36)
Phibro Animal Health (PAHC) in Focus: Stock Jumps 5.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 8:18AM CST
Phibro Animal Health Corporation (PAHC) was a big mover last session, as the company saw its shares rise nearly 6% on the day.
ABAX: 60.93 (+0.65), PAHC: 30.85 (+0.36)
St. Jude Medical HALO US IDE Trial Tests 15mm Heart Valves - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 3:13PM CST
Global medical devices company, St. Jude Medical (STJ), recently launched the HALO U.S. IDE Trial.
CSII: 35.69 (+0.17), PAHC: 30.85 (+0.36), ABAX: 60.93 (+0.65), STJ: 67.48 (+0.65)
ResMed Targets Expansion in HME Market, Acquires Jaysec - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 3:09PM CST
Through Jaysec's acquisition, ResMed (RMD) will experience reduced administrative burden owing to the self-serve software portal specifically designed for HME providers.
CSII: 35.69 (+0.17), PAHC: 30.85 (+0.36), ABAX: 60.93 (+0.65), RMD: 66.25 (+0.79)
Phibro Animal Health Corporation's (PAHC) CEO Jack Bendheim on Q2 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Feb 10, 7:48PM CST
PAHC: 30.85 (+0.36)
Phibro misses 2Q profit forecasts
Automated Insights - Tue Feb 10, 3:48PM CST
TEANECK, N.J. (AP) _ Phibro Animal Health Corp. (PAHC) on Tuesday reported fiscal second-quarter profit of $15.4 million.
PAHC: 30.85 (+0.36)
Phibro Animal misses by $0.01, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Feb 10, 3:28PM CST
PAHC: 30.85 (+0.36)
Phibro Animal Health Corporation Reports Second Quarter
GlobeNewswire - Tue Feb 10, 3:08PM CST
Phibro Animal Health Corporation (Nasdaq
PAHC: 30.85 (+0.36)
Phibro Animal declares $0.10 dividend
Seeking Alpha - at Seeking Alpha - Mon Feb 09, 3:36PM CST
PAHC: 30.85 (+0.36)
Phibro Animal Health Corporation Declares Quarterly Dividend
GlobeNewswire - Mon Feb 09, 3:30PM CST
The Board of Directors of Phibro Animal Health Corporation (Nasdaq
PAHC: 30.85 (+0.36)
Update: Phibro Animal Health Corporation to Host Webcast and Conference Call on December 2014 Quarterly Financial Results
GlobeNewswire - Wed Feb 04, 4:15PM CST
Phibro Animal Health Corporation (Nasdaq
PAHC: 30.85 (+0.36)
Cellular Dynamics International (ICEL) Jumps: Stock Rises 8.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 30, 8:11AM CST
Cellular Dynamics International, Inc. (ICEL) was a big mover last session, as the company saw its shares rise over 8% on the day.
ICEL: 5.27 (+0.02), PAHC: 30.85 (+0.36)
Mead Johnson's US Expansion Drives Q4 Earnings Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 29, 10:09AM CST
Mead Johnson (MJN) achieved positive sales growth in two of its three segments, while sales growth in Asia was not up to the mark owing to Mead Johnson's weak performance in China.
ICUI: 88.98 (+0.42), NXTM: 17.56 (-0.05), MJN: 101.89 (+2.32), PAHC: 30.85 (+0.36)
St. Jude Q4 Earnings Meet Estimates on Modest Sales Growth - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 28, 11:30AM CST
St. Jude Medical Inc (STJ) reported adjusted EPS of $1.03, which was in line with the Zacks Consensus Estimate.
ICUI: 88.98 (+0.42), NXTM: 17.56 (-0.05), PAHC: 30.85 (+0.36), STJ: 67.48 (+0.65)
Medtronic Completes Covidien Acquisition for $50B - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 27, 3:40PM CST
The combined company will now expedite Medtronic's (MDT) three fundamental strategies of therapy innovation, globalization and economic value.
ICUI: 88.98 (+0.42), MDT: 75.26 (+0.33), PAHC: 30.85 (+0.36), COV: 106.71 (-1.36)
Phibro Animal Health Corporation Announces Licensing Agreement With Merial for Phibro's Vaccine Delivery Technology
GlobeNewswire - Mon Jan 26, 3:30PM CST
Phibro Animal Health Corporation (Nasdaq
PAHC: 30.85 (+0.36)
Phibro Animal Health Corporation Announces Entry Into Collaboration Agreement, License Agreement and Intellectual Property Acquisition Agreement
GlobeNewswire - Thu Jan 22, 3:30PM CST
Phibro Animal Health Corporation ("Phibro"
PAHC: 30.85 (+0.36)
Phibro Animal Health Corporation to Host Webcast and Conference Call on December 2014 Quarterly Financial Results
GlobeNewswire - Wed Jan 07, 12:00PM CST
Phibro Animal Health Corporation (Nasdaq
PAHC: 30.85 (+0.36)
Animal Feed Additives - Global Strategic Business Report
M2 - Tue Dec 16, 8:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/24vhpg/animal_feed) has announced the addition of the "Animal Feed Additives - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Animal Feed Additives in US$ Million by the following Product Segments: Antibiotics/Antibacterials, Vitamins, Antioxidants, Amino Acids, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 272 companies including many key and niche players such as: - ADDCON Group - Adisseo France SAS - Ajinomoto Co., Inc. - Alltech Inc. - Archer Daniels Midland Company Key Topics Covered: I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS - Study Reliability and Reporting Limitations - Disclaimers - Data Interpretation & Reporting Level - Quantitative Techniques & Analytics - Product Definitions and Scope of Study - Product Definitions - Antibiotics/Antibacterials - Vitamins - Antioxidants - Amino Acids - Others II. EXECUTIVE SUMMARY 1. OUTLOOK 2. COMPETITIVE LANDSCAPE 3. MARKET TRENDS 4. PRODUCT OVERVIEW 5. REGULATORY & ENVIRONMENTAL ANALYSIS 6. PRODUCT INTRODUCTIONS/APPROVALS 7. RECENT INDUSTRY ACTIVITY 8. FOCUS ON SELECT GLOBAL PLAYERS - ADDCON Group - Adisseo France SAS - Ajinomoto Co., Inc - Ajinomoto Eurolysine S.A.S - Alltech Inc - Archer Daniels Midland Company - BASF SE - Biovet JSC - Cargill, Inc - Provimi Holding - Chr. Hansen - DSM Nutritional - DuPont - Elanco Animal Health - Evonik Industries AG (Germany) - InVivo NSA S.A. (France) - Kemin Industries, Inc. (US) - Lonza Group Ltd (Switzerland) - Novozymes A/S (Denmark) - Novus International, Inc. (US) - Nutreco N.V (the Netherlands) - Phibro Animal Health Corporation (US) - Tessenderlo Group (Belgium) - The Mosaic Company (US) - Zoetis, Inc. (US) 9. GLOBAL MARKET PERSPECTIVE III. MARKET 1. THE UNITED STATES 2. CANADA 3. JAPAN 4. EUROPE 5. ASIA-PACIFIC 6. MIDDLE EAST/AFRICA 7. LATIN AMERICA IV. COMPETITIVE LANDSCAPE For more information visit http://www.researchandmarkets.com/research/24...nimal_feed
ZTS: 45.46 (-0.33), ADM: 48.10 (+0.66), PAHC: 30.85 (+0.36)